|
111, Inc. (YI) Valoración de DCF
CN | Healthcare | Medical - Pharmaceuticals | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
111, Inc. (YI) Bundle
¡Explore el futuro financiero de 111, Inc. (YI) con nuestra calculadora DCF fácil de usar! Ingrese sus suposiciones con respecto al crecimiento, los márgenes y los costos para determinar el valor intrínseco de 111, Inc. (YI) y mejorar su estrategia de inversión.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 541.4 | 1,123.8 | 1,702.3 | 1,851.7 | 2,047.8 | 2,922.5 | 4,170.7 | 5,952.1 | 8,494.3 | 12,122.4 |
Revenue Growth, % | 0 | 107.57 | 51.48 | 8.78 | 10.59 | 42.71 | 42.71 | 42.71 | 42.71 | 42.71 |
EBITDA | -66.0 | -62.9 | -84.2 | -45.2 | -42.6 | -159.4 | -227.4 | -324.6 | -463.2 | -661.0 |
EBITDA, % | -12.19 | -5.6 | -4.95 | -2.44 | -2.08 | -5.45 | -5.45 | -5.45 | -5.45 | -5.45 |
Depreciation | 1.6 | 1.9 | 3.7 | 5.6 | 3.0 | 6.6 | 9.4 | 13.5 | 19.2 | 27.5 |
Depreciation, % | 0.29524 | 0.17087 | 0.21907 | 0.30199 | 0.1457 | 0.22657 | 0.22657 | 0.22657 | 0.22657 | 0.22657 |
EBIT | -67.6 | -64.8 | -88.0 | -50.8 | -45.6 | -166.0 | -236.9 | -338.1 | -482.4 | -688.5 |
EBIT, % | -12.49 | -5.77 | -5.17 | -2.74 | -2.23 | -5.68 | -5.68 | -5.68 | -5.68 | -5.68 |
Total Cash | 84.1 | 204.1 | 115.6 | 120.5 | 89.5 | 300.2 | 428.4 | 611.4 | 872.6 | 1,245.3 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 12.2 | 24.1 | 67.8 | 82.3 | 88.7 | 100.2 | 143.0 | 204.1 | 291.3 | 415.8 |
Account Receivables, % | 2.25 | 2.14 | 3.99 | 4.44 | 4.33 | 3.43 | 3.43 | 3.43 | 3.43 | 3.43 |
Inventories | 66.6 | 105.0 | 153.6 | 205.3 | 194.5 | 299.6 | 427.5 | 610.2 | 870.8 | 1,242.7 |
Inventories, % | 12.3 | 9.34 | 9.02 | 11.09 | 9.5 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
Accounts Payable | 60.9 | 147.0 | 184.6 | 241.8 | 217.6 | 344.0 | 490.9 | 700.6 | 999.9 | 1,426.9 |
Accounts Payable, % | 11.24 | 13.08 | 10.84 | 13.06 | 10.63 | 11.77 | 11.77 | 11.77 | 11.77 | 11.77 |
Capital Expenditure | -3.4 | -3.5 | -8.6 | -4.3 | -1.3 | -10.2 | -14.5 | -20.7 | -29.5 | -42.1 |
Capital Expenditure, % | -0.62271 | -0.31092 | -0.50453 | -0.23359 | -0.06572729 | -0.3475 | -0.3475 | -0.3475 | -0.3475 | -0.3475 |
Tax Rate, % | -11.19 | -11.19 | -11.19 | -11.19 | -11.19 | -11.19 | -11.19 | -11.19 | -11.19 | -11.19 |
EBITAT | -66.3 | -63.7 | -93.9 | -55.2 | -50.7 | -164.8 | -235.2 | -335.6 | -479.0 | -683.5 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -86.0 | -29.4 | -153.6 | -62.9 | -68.8 | -158.6 | -264.1 | -376.8 | -537.8 | -767.5 |
WACC, % | 5.39 | 5.39 | 5.43 | 5.43 | 5.43 | 5.41 | 5.41 | 5.41 | 5.41 | 5.41 |
PV UFCF | ||||||||||
SUM PV UFCF | -1,735.0 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -783 | |||||||||
Terminal Value | -22,940 | |||||||||
Present Terminal Value | -17,625 | |||||||||
Enterprise Value | -19,360 | |||||||||
Net Debt | -22 | |||||||||
Equity Value | -19,338 | |||||||||
Diluted Shares Outstanding, MM | 84 | |||||||||
Equity Value Per Share | -229.39 |
What You Will Receive
- Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring pre-filled financial data for 111, Inc. (YI).
- Accurate Data Insights: Access to historical performance metrics and projected estimates (highlighted in the yellow cells).
- Flexible Forecasting: Modify key assumptions such as revenue growth, EBITDA %, and WACC as needed.
- Instant Calculations: Quickly observe how your inputs affect the valuation of 111, Inc. (YI).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Interface: Organized for simplicity and usability, complete with detailed instructions.
Key Features
- Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for 111, Inc. (YI).
- WACC Estimator: Features a pre-built Weighted Average Cost of Capital sheet with options for customizable inputs.
- Adjustable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates to suit your analysis.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for 111, Inc. (YI).
- Interactive Dashboard and Charts: Visual representations that summarize essential valuation metrics for straightforward analysis.
How It Works
- Download the Template: Gain immediate access to the Excel-based 111, Inc. (YI) DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional factors.
- Instant Calculations: The model automatically recalculates 111, Inc.'s (YI) intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the findings to inform your investment or financial analysis.
Why Choose This Calculator for 111, Inc. (YI)?
- Accurate Data: Up-to-date financials for 111, Inc. ensure dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Built-in calculations save you the hassle of starting from scratch.
- Professional-Grade Tool: Ideal for investors, analysts, and consultants focused on 111, Inc. (YI).
- User-Friendly: Easy-to-navigate design and clear instructions make it accessible for all users.
Who Should Use This Product?
- Investors: Evaluate 111, Inc. (YI)'s valuation prior to making investment decisions.
- CFOs and Financial Analysts: Enhance valuation methodologies and assess financial forecasts.
- Startup Founders: Discover how established companies like 111, Inc. (YI) are assessed in the market.
- Consultants: Provide expert valuation analyses and reports for clients.
- Students and Educators: Utilize current data to practice and instruct on valuation strategies.
What the Template Contains
- Pre-Filled Data: Includes 111, Inc.'s (YI) historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze 111, Inc.'s (YI) profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.